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Synopsis
Background—World mapping is an important tool to visualize stroke burden and its trends in 
various regions and countries.
Objectives—To show geographic patterns of incidence, prevalence, mortality, disability-
adjusted life-years (DALYs) and years lived with disability (YLDs), and their trends for ischemic 
stroke (IS) and hemorrhagic stroke (HS) in the world for 1990 to 2013.
Methodology—Stroke incidence, prevalence, mortality, DALYs and YLDs were estimated 
following the general approach of the Global Burden of Disease (GBD) 2010 with several 
important improvements in methods. Data were updated for mortality (through April 2014) and 
stroke incidence, prevalence, case fatality, and severity through 2013. Death was estimated using 
an ensemble modelling approach. A new software package, DisMod-MR 2.0 was used as part of a 
custom modelling process to estimate YLDS. All rates were age-standardized to new GBD 
estimates of global population. All estimates have been computed with 95% uncertainty intervals 
(UI).
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Results—Age-standardized incidence, mortality, prevalence and DALYs/YLDs declined over 
the period from 1990 to 2013. However, the absolute number of people affected by stroke has 
substantially increased across all countries in the world over the same time period, suggesting that 
the global stroke burden continues to increase. There were significant geographical (country and 
regional) differences in stroke burden in the world, with the majority of the burden borne by low- 
and middle-income countries.
Conclusions—Global burden of stroke has continued to increase in spite of dramatic declines in 
age-standardized incidence, prevalence, mortality rates, and disability. Population growth and 
ageing have played an important role in the observed increase in stroke burden.
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Appendix
GBD Stroke Collaborators (in alphabetical order by country)
Argentina (Maria Cecilia Bahit); Australia (Amanda Thrift, Atte Meretoja, Bill Stavreski, 
Craig Anderson, Edwin Pearse, Geoffrey Donnan, Graeme Hankey, Mark T. Mackay, 
Stephen Davis, Zanfina Ademi; Austria (Michael Brainin); Azerbaijan (Tural Guliyev); 
Bahrain (Randah R. Hamadeh); Barbados (Heather Harewood, Karen Springer); Brazil 
(Iuri da Costa Leite, Jefferson Gomes Fernandes, Norberto Cabral, Paulo Lotufo); Bulgaria 
(Klara Dokova); Canada (Farshad Pourmalek, Luciano A. Sposato, M. Patrice Lindsay, 
Patricia Riccio); Chile (Pablo M. Lavados); China (Bin Li, Chuanhua Yu, Guohong Jiang, 
Jixiang Ma, Maigeng Zhou, Ming Liu, Shankuan Zhu, Wenzhi Wang, Xiaofeng Liang, 
XXX Deji, Yong Zhang); Colombia (Gabriel Alcalá-Cerra, Gabrielle DeVeber), Denmark 
(Hanne Christensen, Thomas Truelsen); Egypt (Foad Abd-Allah); Ethiopia (Awoke 
Temesgen, Berhe Weldearegawi Sahle, Semaw Abera, Yohannes Adama Melaku), Fiji 
(Devina Nand); France (Maurice Giroud); Germany (Jost B. Jonas, Matthias Endres, 
Ronny Westerman); Greece (Konstantinos Stroumpoulis); India (Dorairaj Prabhakaran, 
Jeyaraj Durai Pandian, Man Mohan Mehndiratta, Nobhojit Roy, Panniyammakal Jeemon, 
Rajeev Gupta, Vasanthan Rajagopalan); Indonesia (Soewarta Kosen, Tati Suryati Warouw); 
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Iran (Reza Malekzadeh); Ireland (Martin O'Donnell); Israel (David Tanne, Natan 
Bornstein); Italy (Stefano Ricci, Valeria Caso); Japan (Yoshihiro Kokubo, Yukito 
Shinohara); Jordan (Majed Asad); Kenya (Vitalis Kizito Bwire); Korea (Sun Ha Jee, 
Young-Ho Khang); Malaysia (Kim Yunjin, Ramesh Sahathevan); Morocco (Fortune 
Gankpe); Myanmar (Chaw Yin Myint); New Zealand (Priya Parmar, Rita Krishnamurthi, 
Suzanne Barker-Collo, Valery Feigin); Nigeria (Rufus Olusola Akinyemi); Norway (Ole 
Norheim); Qatar (Shams Eldin Khalifa); Russia (Michael Kravchenko, Michael Piradov, 
Nicolay Shalamov, Vasiliy Vlassov, Yuri Varakin); Rwanda (Jean De Dieu Ngirabega, Jean 
Pierre Nyemazi, Marie Aimee Muhimpundu); Saudi Arabia (Mohammad Saeedi, Neeraj 
Bedi); Singapore (Narayanaswamy Venketasubramanian); South Africa (Andre Pascal 
Kengne); Spain (David Rojas-Rueda, Ferrán Catalá-López); Sri Lanka (Samath 
Dharmaratne); Sweden (Bo Norrving, Rasmus Havmoeller); The Netherlands (Johanna M. 
Geleijnse); Uganda (Leo Atwine); United Kingdom (Amitava Banerjee, Charles Wolfe, 
Derrick Bennett, Finbar O'Callaghan, Ivy Shiue, Julia Critchley, Majid Ezzati, Michael 
Soljak, Myles Connor, Peter Rothwell, Rajiv Chowdhury, Rustam Al-Shahi Salman, 
William Whiteley, Zhengming Chen); Uruguay (Mercedes Colomar); USA (Adnan 
Durrani, Anand Dayama, Andrew Moran, Awoke Misganaw, Brett Kissela, Catherine 
Amlie-Lefond, Catherine O. Johnson, Cheng Huang, Chugh Sumeet, Daniel Kim, David 
Cundiff, David Lawrence Tirschwell, Dhruv Kazi, Dima Qato, Edmond Kabagambe, Eric 
Ding, Gene Bukhman, Gene Kwan, George Mensah, George Thurston, Grant Nguyen, 
Gregory A. Roth, Ismael Campos-Nonato, Josef Coresh, Kate Lefondulq, Kevin Sheth, 
Matthew Corriere, Mohammad H. Forouzanfar, Mohsen Naghavi, Nana Mainoo, Norman 
Beauchamp, Ralph Sacco, Richard Gillum, Sanjay Basu, Stephen Schwartz, Sumeet Chugh, 
Teresa Fung, Tim Byers, Uchechukwu K.A. Sampson, Walter Rocca, Warren Lo).
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1. 
Age-standardized annual prevalence (per 100,000) of ischemic stroke in 2013
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2. 
Age-standardized annual prevalence (per 100,000) of hemorrhagic stroke in 2013
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3. 
Age-standardized annual mortality rates (per 100,000) of ischemic stroke in 2013
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4. 
Age-standardized annual mortality rates (per 100,000) of hemorrhagic stroke in 2013
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5. 
Age-standardized annual DALYs rates (per 100,000) due to ischemic stroke in 2013
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6. 
Age-standardized annual DALYs rates (per 100,000) due to hemorrhagic stroke in 2013
Feigin et al. Page 9
Neuroepidemiology. Author manuscript; available in PMC 2016 October 28.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
7. 
Percent change in age-standardized prevalence due to ischemic stroke for 1990–2013
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8. 
Percent change in age-standardized prevalence due to hemorrhagic stroke for 1990–2013
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9. 
Percent change in age-standardized mortality rates due to ischemic stroke for 1990–2013
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10. 
Percent change in age-standardized mortality rates due to hemorrhagic stroke for 1990–2013
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